A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 1393
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : PON1
Long Form : paraoxonase 1
No. Year Title Co-occurring Abbreviation
2019 Acute phase proteins and biomarkers of oxidative status in feline spontaneous malignant mammary tumours. APP, BChE, CUPRAC, FRAP, GPOX, Hp, IGF1, SAA
2019 Anti-inflammatory, anti-oxidant and hepatoprotective effects of lactoferrin in rats. GPx, IL, LF, MDA, SOD
2019 Association between paraoxonase-1 gene Q192R and L55M polymorphisms and risk of gastric cancer: A case-control study from Iran. PCR-RFLP
2019 Association of paraoxonase 1 (PON1) L55M and PON1 Q192R gene polymorphisms and risk of psoriasis. ---
2019 Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease. CR
2019 Associations between paraoxonase 1 (PON1) polymorphisms and susceptibility and PON1 activity in rheumatoid arthritis patients, and comparison of PON1 activity in patients and controls: a meta-analysis. RA
2019 Bovine lactoferrin ameliorates antioxidant esterase activity and 8-isoprostane levels in high-cholesterol-diet fed rats. AI, ARE, bLF, HCD-Fed, HDL-C, LDL-C, TC, TG
2019 Cardiovascular Insufficiency, Abdominal Sepsis, and Patients' Age Are Associated with Decreased Paraoxonase-1 (PON1) Activity in Critically Ill Patients with Multiple Organ Dysfunction Syndrome (MODS). CVI, ICU, MODS
2019 Changes in lecithin: cholesterol acyltransferase, cholesteryl ester transfer protein and paraoxonase-1 activities in patients with colorectal cancer. CETP, CRC, HDL-C, LCAT
10  2019 Do CO2 and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients. CA, CAT, HNC, XO
11  2019 Effect of high-density lipoprotein on oocyte maturation and bovine embryo development in vitro. apoAI, COCs, HDL, HDL-P, IVM
12  2019 Effect of yerba mate and green tea on paraoxonase and leptin levels in patients affected by overweight or obesity and dyslipidemia: a randomized clinical trial. GT, RCT, YM
13  2019 Effects of Daily Consumption of Cashews on Oxidative Stress and Atherogenic Indices in Patients with Type 2 Diabetes: A Randomized, Controlled-Feeding Trial. BMI, FPG, hs-CRP, T2DM, TAC, WC
14  2019 Effects of exercise on reverse cholesterol transport: A systemized narrative review of animal studies. CETP, CYP7A1, HDL, LDLR, NPC1L1, RCTr, SR-BI
15  2019 Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever. CCHF, CCHFV, HDL
16  2019 Evaluating the link between Paraoxonase-1 levels and Alzheimer's disease development. AD, HDL
17  2019 Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata. AA, OSI, TOS
18  2019 Gender-dependent difference in serum paraoxonase 1 levels of Hanwoo, Korean native cattle, and a positive association with meat quality. ---
19  2019 HDL Particle Size and Functionality Comparison between Patients with and without Confirmed Acute Myocardial Infarction. AMI, CPs, CVDs, HDL, HSR, LLS, REAMI
20  2019 Identification of Major Esterase Involved in Hydrolysis of Soft Anticholinergic (2R3'R-SGM) Designed From Glycopyrrolate in Human and Rat Tissues. ---
21  2019 In silico Molecular Docking and ADME Studies of 1,3,4-Thiadiazole Derivatives in Relation to in vitro PON1 Activity. ADME
22  2019 Increased Levels of Acetylcholinesterase, Paraoxonase 1, and Copper in Patients with Moderate Depression- a Preliminary Study. AChE, GHQ-28, RBC
23  2019 Increased PON lactonase activity in morbidly obese patients is associated with impaired lipid profile. RYGB
24  2019 Influence of nutritional factors and the PON1 C(-107)T polymorphism on paraoxonase-1 activity in childhood. ---
25  2019 Influence of Surgical Procedures on Serum Paraoxonase-1-Related Variables and Markers of Inflammation in Hospitalized Patients. CRP
26  2019 Interaction between MTHFR 677C>T, PON1 192Q>R and PON1 55L>M polymorphisms and its effect on non-recurrent spontaneous abortion in Mexican women. ---
27  2019 Intrafollicular paraoxonase 1 activity and the steroidogenic potential of the first post-partum dominant follicle in dairy cows. ---
28  2019 Investigation of pesticide exposure by genotoxicological, biochemical, genetic polymorphic and in silico analysis. BChE, BMCyt, Br, PIXE, Rb, TL, XRCC1
29  2019 Modulation of gastric acid secretion by cannabinoids in rats. D-G, MDA, NO, s.c
30  2019 Organochlorine and organophosphorous pesticides may induce colorectal cancer; A case-control study. AChE, CRC, GC, MDA, MSP, OCPs, OPPs, TAC
31  2019 Oxidative stress and phenotype frequencies of paraoxonase-1 in teratozoospermia. TAS, TOS
32  2019 Para-occupational exposure to pesticides, PON1 polymorphisms and hypothyroxinemia during the first half of pregnancy in women living in a Mexican floricultural area. OP, OR, PCR, TSH
33  2019 Paraoxonase 1 (PON1) attenuates sperm hyperactivity and spontaneous acrosome reaction. AR, CASA, HA, SAR, WHO
34  2019 Paraoxonase 1 (PON1) Q192R and L55M polymorphisms, lipid profile, lipid peroxidation and lipoprotein-a levels in Turkish patients with pregnancy-related disorders. GDM, MDA, PE, SNPs
35  2019 Paraoxonase 1 (PON1) was Negatively Associated with Intervertebral Disc Degeneration (IVDD). IHC, IVDD, NP
36  2019 Paraoxonase 1 Activity, Polymorphism and Atherosclerosis Risk Factors in Patients Undergoing Coronary Artery Surgery. CHD, HDL, HDL-C, LDL-C
37  2019 Paraoxonase 1 in endothelial cells impairs vasodilation induced by arachidonic acid lactone metabolite. 5,6-EET, EDHF, HDL, PON1KO, WT
38  2019 Paraoxonase 1 serum activity in women: the effects of menopause, the C(-107)T polymorphism and food intake. ---
39  2019 Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage. APO A1, CEC, HDL-C
40  2019 Paraoxonase-1 and arylesterase levels in patients with ulcerative colitis. ARE, UC
41  2019 Paraoxonase-1 genetic polymorphisms in organophosphate metabolism. OPs
42  2019 Paraoxonase-1: Characteristics and Role in Atherosclerosis and Carotid Artery Disease. HDL, LDL
43  2019 Plasma Levels of Prebeta1-HDL Are Significantly Elevated in Non-Dialyzed Patients with Advanced Stages of Chronic Kidney Disease. CKD, eGFR, HDL, HDL-C, LCAT, MPO, TAG
44  2019 Polymorphisms in the anti-oxidant paraoxonase-1 (PON1) gene associated with fertility of postpartum dairy cows. SNPs
45  2019 PON-1 carbamylation is enhanced in HDL of uremia patients. HDL
46  2019 PON1 arylesterase activity, HDL functionality and their correlation in malnourished children. HDL, TC, TG, TPX
47  2019 PON1 is a disease modifier gene in amyotrophic lateral sclerosis: association of the Q192R polymorphism with bulbar onset and reduced survival. SNPs
48  2019 Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes. HDL
49  2019 Resveratrol exhibits an effect on attenuating retina inflammatory condition and damage of diabetic retinopathy via PON1. DR, GO, HG, RRECs, STZ
50  2019 Serum paraoxonase 1 activity is paradoxically maintained in nonalcoholic fatty liver disease despite low HDL cholesterol. FLI, MetS, NAFLD
51  2019 The combined utility of myeloperoxidase (MPO) and paraoxonase 1 (PON1) as two important HDL-associated enzymes in coronary artery disease: Which has a stronger predictive role? CAD, MPO, OR, ROC
52  2019 Therapeutic effect of simvastatin on DMBA-induced breast cancer in mice. CA15-3, DMBA, MDA, PGE2, TAC, TOS
53  2019 Visfatin, PON-1 Levels in Iraqi Hyperthyroidism Patient's with Dyslipidemia. HDL, LDL, TC, TG, TSH, VLDL
54  2018 A case-control study: The association of serum paraoxonase 1 activity and concentration with the development of type 2 diabetes mellitus. T2D
55  2018 Abnormalities in the relationship of paraoxonase 1 with HDL and apolipoprotein A1 and their possible connection to HDL dysfunctionality in type 2 diabetes. ApoA1, apoB, Chol-T, HDL-C, LDL-C, LPO, TG
56  2018 Activity of Antioxidant Enzymes and Their Association with Lipid Profile in Mexican People without Cardiovascular Disease: An Analysis of Interactions. FRAP, SOD1
57  2018 Activity of paraoxonase 1 (PON1) on HDL2 and HDL3 subclasses in renal disease. CKD, ESRD
58  2018 Activity of the antioxidant enzyme paraoxonase in Argentinean children living at high altitude. BA, HDL-C, SAC
59  2018 Ancient convergent losses of Paraoxonase 1 yield potential risks for modern marine mammals. ---
60  2018 Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases. AAV, CD, HDL, IBD, IgG, MCTD, pSS, SSc, TAC, UC
61  2018 Association between dementia and vascular disease-associated polymorphisms in a Tunisian population. ACE, APOE
62  2018 Association of Dyslipidemia, Oxidative Stress, and Inflammation With Redox Status in VLDL, LDL, and HDL Lipoproteins in Patients With Renal Disease. AOPPs, DOI, ELISA, HDL, LDL, VLDL
63  2018 Association of paraoxonase-1 gene polymorphisms with insulin resistance in South Indian population. GLUT4, PCR-RFLP, SNP
64  2018 Association of PON1 gene polymorphisms with polycystic ovarian syndrome risk: a meta-analysis of case-control studies. PCOS
65  2018 Associations of the PON1 rs854560 polymorphism with plasma lipid levels: a meta-analysis. CI, CNKI, HDL-C, SMD
66  2018 Bariatric surgery improves lipoprotein profile in morbidly obese patients by reducing LDL cholesterol, apoB, and SAA/PON1 ratio, increasing HDL cholesterol, but has no effect on cholesterol efflux capacity. CEC, HDL, LDL, LDL-C, SAA
67  2018 Biomarkers of oxidative stress in blood of workers exposed to non-cholinesterase inhibiting pesticides. AChE, FRAS, GGT, TBARS
68  2018 Candidate gene polymorphisms related to lipid metabolism in Asian Indians living in Durban, South Africa. CETP, HDL-C, LEP, LPL, MetS
69  2018 Changes in lipid profile parameters and PON1 status associated with L55M PON1 polymorphism, overweight and exposure to tobacco smoke. PCR
70  2018 Changes in Oxidized Low-Density Lipoprotein Rather Than in Paraoxonase1 are Associated with Changes in the Leptin/Leptin Receptor Ratio in Obese Children During Weight-Loss Therapy. oxLDL, sOB-R
71  2018 Cholesteryl ester transfer protein (CETP), HDL capacity of receiving cholesterol and status of inflammatory cytokines in patients with severe heart failure. BNP, CETP, HF, LCAT, oxLDL
72  2018 Correlation of High-Density Lipoprotein-Associated Paraoxonase 1 Activity With Systemic Inflammation, Disease Activity, and Cardiovascular Risk Factors in Psoriatic Disease. CVD, DAS28, HDL, PsA, PsO
73  2018 Correlation of Paraoxonase-1 with the Severity of Crohn's Disease. AUC, CD, CRP, Hb, HDL, Ht, LDL, MDA, PLT, ROC, TC, TG, WBC
74  2018 Cross-sectional correlates of paraoxonase 1 and soluble intercellular adhesion molecule-1 in metabolic syndrome patients with and without diabetes. AIP, BAI, CI, HC, MetS, sICAM-1, T2DM, WC, WHR
75  2018 Daily supplementation with fresh pomegranate juice increases paraoxonase 1 expression and activity in mice fed a high-fat diet. HDL, PJ
76  2018 Decreased serum PON1 arylesterase activity in familial hypercholesterolemia patients with a mutated LDLR gene. FH, HDL, LDL, LDLR
77  2018 Decreases in Paraoxonase-1 Activities Promote a Pro-inflammatory Effect of Lipids Peroxidation Products in Non-smoking and Smoking Patients with Acute Pancreatitis. AP, CH, HDL, MDA, oxLDL
78  2018 Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes. IDL-C, Lp-PLA2, VLDL-C
79  2018 DNA variants and organophosphate neurotoxicity among emerging farmers in the Western Cape of South Africa. NAT2, OP, XMEs
80  2018 Effect of Agraz (Vaccinium meridionale Swartz) on High-Density Lipoprotein Function and Inflammation in Women with Metabolic Syndrome. HDL, MetS, MPO
81  2018 Effect of Blood Phenylalanine Levels on Oxidative Stress in Classical Phenylketonuric Patients. GSH-Px, OSI, TAS, TOS
82  2018 Effect of serum paraoxonase-1 (PON1) activity on follicular development and pregnancy rate in cattle. AI, TAI
83  2018 Effects of a 12-week aerobic exercise on markers of hypertension in men. DBP, SBP
84  2018 Effects of Inducible Nitric Oxide Synthase Inhibition on Cardiovascular Risk of Adult Endotoxemic Female Rats: Role of Estrogen. HR, iNOS, MAP, OVX+E, SMT, TRAP
85  2018 Effects of Nigella sativa Extracts on the Lipid Profile and Uncoupling Protein-1 Gene Expression in Brown Adipose Tissue of Mice. BAT, MDA, TAC, TQ, UCP1
86  2018 Effects of paraoxonase 1 on the cytodifferentiation and mineralization of periodontal ligament cells. AgP, ALPase, hPDL, PDL, SNPs
87  2018 Effects of PON1 Gene Promoter DNA Methylation and Genetic Variations on the Clinical Outcomes of Dual Antiplatelet Therapy for PatientsUndergoing Percutaneous Coronary Intervention. ARUs, CAD, CI, OR, PCI, SNPs
88  2018 European versus Asian differences for the associations between paraoxonase-1 genetic polymorphisms and susceptibility to type 2 diabetes mellitus. CIs, ORs, T2DM
89  2018 Evaluation of the prognostic value of paraoxonase 1 in the recurrence and metastasis of hepatocellular carcinoma and establishment of a liver-specific predictive model of survival. AJCC, GSEA
90  2018 Exogenous (Pomegranate Juice) or Endogenous (Paraoxonase1) Antioxidants Decrease Triacylglycerol Accumulation in Mouse Cardiovascular Disease-Related Tissues. CVD, HDL, PJ, rePON1, VAT and SAT
91  2018 Functional implications of single nucleotide polymorphisms rs662 and rs854860 on the antioxidative activity of paraoxonase1 (PON1) in patients with rheumatoid arthritis. CVD, ELISA, RA
92  2018 Functional SNP in the 3'UTR of PON1 is Associated with the Risk of Calcific Aortic Valve Stenosis via MiR-616. CAVS, EF
93  2018 Generalized Anxiety Disorder (GAD) and Comorbid Major Depression with GAD Are Characterized by Enhanced Nitro-oxidative Stress, Increased Lipid Peroxidation, and Lowered Lipid-Associated Antioxidant Defenses. AOPP, BD, GAD, HDL, LOOH, MDA, MDD, NOx, UA
94  2018 Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes. AIP, T2D, TC
95  2018 Genotype-phenotype Analysis of Paraoxonase 1 in Schizophrenic Patients Treated with Atypical Antipsychotics. AREase, CVD, POase
96  2018 Genotypes of Common Polymorphisms in the PON1 Gene Associated with Paraoxonase Activity as Cardiovascular Risk Factor. AREase, CAD
97  2018 High levels of oxidized fatty acids in HDL are associated with impaired HDL function in patients with active rheumatoid arthritis. HDL, HETE, HII, HODE, LDL, MPO, OA, RA, SF
98  2018 High-density lipoproteins (HDL) composition and function in preeclampsia. ApoA1, eNOS, HDL, NP, PE, VCAM-1
99  2018 Hypolipidemic, antioxidant and antiatherogenic property of sardine by-products proteins in high-fat diet induced obese rats. BW, CAS, FI, LCAT, SBy-P, TC, TG
100  2018 Identification of human, rat and mouse hydrolyzing enzymes bioconverting amino acid ester prodrug of ketoprofen. AChE, BChE, LAT1